Tech Center 1600 • Art Units: 1623 1693
This examiner grants 54% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18558874 | NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS, COMBINATIONS AND USES RELATED THERETO | Non-Final OA | EMORY UNIVERSITY |
| 17620645 | PURIFICATION METHODS FOR CARBOHYDRATE-LINKED OLIGONUCLEOTIDES | Final Rejection | AMGEN INC. |
| 19275384 | VERSATILE SYNTHETIC ROUTE FOR NEUTRAL MORPHOLINO OLIGONUCLEOTIDES WITH PHOSPHORYL GUANIDINIUM (PG) BACKBONE | Final Rejection | Bio-Synthesis, Inc. |
| 18259368 | DISACCHARIDES FOR TREATING BONE DISEASES | Non-Final OA | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE |
| 17616966 | METHODS OF REJUVENATING AGED TISSUE BY INHIBITING 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE (15-PGDH) | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18031832 | CRYSTALLINE POLYMORPHIC FORMS OF STING AGONISTS ASSOCIATED WITH METAL IONS CAPABLE OF MODULATING AN IMMUNE RESPONSE | Non-Final OA | The Regents of the University of Michigan |
| 18539559 | OIL-RESISTANT AGENT | Non-Final OA | DAIKIN INDUSTRIES, LTD. |
| 18558808 | COMPOSITION AND METHODS USING COMBINATION OF NARH AND NR TO PRODUCE INTRACELLULAR NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD+) | Non-Final OA | SOCIETE DES PRODUITS NESTLE S.A. |
| 18255757 | STABLE AQUEOUS COMPOSITION FOR PRETERM TO PROMOTE EARLY POSTNAL GROWTH | Final Rejection | SOCIETE DES PRODUITS NESTLE S.A. |
| 17633254 | HYBRID AMIDE DERIVATIVES OF AMPHOTERICIN B | Final Rejection | The Board of Trustees of the University of Illinois |
| 17291588 | METHODS FOR CONSOLIDATING ANTIBIOTIC-ELUTING POLYMERIC MATERIALS | Non-Final OA | THE GENERAL HOSPITAL CORPORATION |
| 17258868 | POLYMER COMPOUND AND PROMOTER FOR INTRODUCING COMPOUND INTO CELLS USING SAME | Non-Final OA | ADEKA CORPORATION |
| 18269213 | MOLECULE FOR INDUCING SPONTANEOUS CALCIFICATION OF TUMOR CELLS AND USE THEREOF | Non-Final OA | ZHEJIANG UNIVERSITY |
| 18263124 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | Non-Final OA | Daiichi Sankyo Company, Limited |
| 18252838 | COMPLEX OF BETA-GLUCAN AND NUCLEIC ACID HAVING CONTROLLED PARTICLE SIZE | Final Rejection | DAIICHI SANKYO COMPANY, LIMITED |
| 17918725 | THYCLOTIDES | Final Rejection | The United States of America,as represented by the Secretary,Department of Health and Human Services |
| 18742011 | HYDROPHOBIC INTERACTION CHROMATOGRAPHY FOR PURIFICATION OF OLIGONUCLEOTIDES | Final Rejection | Biogen MA Inc. |
| 18655834 | Drug Conjugates of Sugar Derivatives and Uses Thereof as Senolytic Agents | Non-Final OA | Rubedo Life Sciences, Inc. |
| 18121090 | OPTIMIZED METHOD FOR DECONTAMINATING PRODUCTION OF GLUCOSE POLYMERS AND GLUCOSE POLYMER HYDROLYZATES | Non-Final OA | ROQUETTE FRERES |
| 18693693 | Triple Drug Combination (Metformin, Simvastatin, Digoxin) for Targeted Treatment of Colorectal Cancer | Non-Final OA | Whispergenics. Inc. |
| 17610440 | ANTIFUNGAL AGENTS FOR CANDIDA AURIS DECOLONIZATION | Non-Final OA | Scynexis, Inc. |
| 17610900 | NUCLEIC ACID POLYMER WITH AMINE-MASKED BASES | Final Rejection | Nuclera Ltd |
| 18035987 | COMPOSITION, PHARMACEUTICAL COMPOSITION, USE OF A STABLE TOPICAL COMPOSITION COMPRISING A NANOEMULSION AND OF AT LEAST ONE ANTILEISHMANIAL COMPOUND, AND METHOD FOR THE TREATMENT OF CUTANEOUS LEISHMANIASIS | Final Rejection | Fundação Oswaldo Cruz |
| 18569567 | ONE-POT PRODUCTION OF CELLULOSE NANOCRYSTALS | Non-Final OA | NANO-GREEN BIOREFINERIES INC. |
| 18564331 | NOVEL PHENYLPROPANOID COMPOUND | Non-Final OA | NABOCUL COSMETICS CO., LTD. |
| 18000962 | RNA PURIFICATION METHOD | Non-Final OA | ETHERNA IMMUNOTHERAPIES NV |
| 18288057 | METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND | Non-Final OA | NIPPON SHINYAKU CO., LTD. |
| 17542693 | FLAVONE DERIVATIVE FOR TREATING TUMORS AND USE THEREOF | Non-Final OA | SICHUAN FUSHENGYUAN TECHNOLOGY CO., LTD |
| 18266331 | PHARMACEUTICAL APPLICATION OF FUSED RING PHENOLIC COMPOUNDS | Non-Final OA | RISEN (SUZHOU) PHARMA TECH CO. LTD. |
| 18281352 | N-(2-AMINOETHYL)MORPHOLINE-BASED RNA ANALOGS, METHOD FOR THE PREPARATION AND USE THEREOF | Non-Final OA | Uniwersytet Warszawski |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy